International
Available Domestic
U.S Domestic
Available Domestic
Dragon Pharma
Dragon Pharma Adipotide 10 mg FTPP Research Peptide Vial
Injection · 10 mg · vial
In stock · ships within 24h
Out of stock
$120.00
Dragon Pharma Adipotide is a 10 mg lyophilized vial of prohibitin-targeting peptide 1, a peptidomimetic designed to cut the blood supply to white fat tissue rather than to burn fat directly. Its clinical program was stopped over kidney toxicity, so it is supplied strictly as research material.
GMP-manufactured, HPLC-verified with the Certificate of Analysis on file. Adipotide for sale with U.S. domestic and international shipping.
Shipping
Not available in this combination
Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted
Product overview
Dragon Pharma Adipotide 10 mg FTPP Research Vial
Adipotide, formally prohibitin-targeting peptide 1, is one of the more unusual molecules in this catalogue. It is a peptidomimetic with two working parts: a homing sequence that recognizes a protein on the blood vessels feeding white adipose tissue, and a proapoptotic domain that kills the cells it lands on. The result is not fat burning but a loss of blood supply to fat tissue, which is why the animal results looked dramatic and why the safety questions are equally dramatic.
- 10 mg lyophilized powder per vial, one pack option
- Prohibitin-targeting peptide 1, also called FTPP
- GMP-manufactured and HPLC-verified, COA per batch
- U.S. domestic and international shipping options
How Adipotide Works
The targeting arm binds prohibitin on the endothelial cells of white fat vessels, and the attached apoptotic sequence then destroys them, starving that fat depot. In primate work the material was given daily for 28 days by the intravenous route, which is the only dosing pattern the sources describe; no human half-life and no human weight-loss endpoint exist. The program ended because of kidney toxicity, not because of failure to act, and that is the fact a buyer should weigh most heavily. This is a fundamentally different mechanism from the lipolytic fragment AOD 9604 or from incretin-based options such as Semaglutide.
Reconstitution & Research Use
Add bacteriostatic water down the glass wall and swirl rather than shake. Ten milligrams with 2 ml gives 5 mg/ml, so 0.1 ml carries 500 mcg and reads as 10 units on a U-100 insulin syringe. Because the studied route was intravenous and the concern is renal, community material around this peptide is thin and cautious, and no research amount can be presented as safe. Reported problems in the literature are kidney injury, protein in the urine and dehydration, with no hepatic picture at all. The nearest fat-loss comparisons in the catalogue are the fragment AOD 9604 5 mg and Retatrutide.
Quality & Authenticity
Each batch is produced under GMP conditions and checked by HPLC, with a Certificate of Analysis held for the batch. Store the powder cold and dark and keep any mixed solution refrigerated.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Brand | Dragon Pharma |
| Active Substance | Adipotide (FTPP) |
| Dosage | 10 mg per vial |
| Package | 1 lyophilized vial |
| Form | Freeze-dried powder, requires reconstitution |
| Drug Class | Research peptide, proapoptotic peptidomimetic |
| Manufacturing | GMP-certified |
| Testing | HPLC per batch, COA on file |
| Shipping | U.S. domestic and international |
Stacks
FAQ
Before you ask
Questions, answered
Adipotide is the trade name of prohibitin-targeting peptide 1, a peptidomimetic that pairs a homing sequence for the blood vessels of white fat with a sequence that triggers cell death. It does not burn fat; it removes the blood supply that keeps the fat tissue alive. It has no approved use and is supplied as research material.
Because of kidney toxicity. The animal work showed the peptide acted on fat tissue, and primate studies used a 28-day course of daily intravenous dosing, but the renal findings were serious enough to stop development. There is no human weight-loss endpoint and no human half-life in the sources, so the risk is the only fully documented part of the story.
Add bacteriostatic water slowly down the inside wall and swirl, never shake. Ten milligrams with 2 ml gives 5 mg/ml, so 0.1 ml carries 500 mcg and reads as 10 units on a U-100 insulin syringe. That is laboratory arithmetic only: the studied route was intravenous rather than subcutaneous, and no safe research amount appears anywhere in the sources.
The problem profile is renal: kidney injury, protein in the urine and dehydration are the findings that ended development. Notably, there is no hepatic concern and no water retention described, which makes this molecule different from almost everything else on the shelf. No side-effect frequency table for humans exists at all.
The 10 mg vial is listed on this page as research material with U.S. domestic and international shipping, and price and stock appear against the option selector above. The peptide is not named individually in the prohibited list, but it is an unapproved substance and class S0 covers that situation, so it is not an option for anyone in a testing pool.
No reviews yet
Be the first to share your experience with Dragon Pharma Adipotide 10 mg FTPP Research Peptide Vial
Log in to write a reviewComplete the cycle
